Text Size

Prospective Memory in Parkinson's Disease (ProMem)

This study has been completed.
Sponsor:
Collaborator:
National Institutes of Health (NIH)
Information provided by:
Washington University School of Medicine
ClinicalTrials.gov Identifier:
NCT00913640
First received: June 1, 2009
Last updated: July 14, 2009
Last verified: July 2009
History of Changes
  Purpose

The investigators tested whether prospective memory is impaired in individuals with Parkinson's Disease compared to controls using reliable and validated experimental measures. Also, the investigators assessed the impact of Parkinson's medication on prospective memory performance in PD to better estimate prospective memory function in PD patients' everyday (chronically treated) life.


Condition
Memory
Prospective Memory
Parkinson's Disease

Study Type: Observational
Study Design: Observational Model: Case Control
Time Perspective: Cross-Sectional
Official Title: Prospective Memory in Parkinson's Disease

Resource links provided by NLM:

U.S. FDA Resources

Further study details as provided by Washington University School of Medicine:

Primary Outcome Measures:
  • Prospective Memory [ Designated as safety issue: No ]

Groups/Cohorts
PD Group
Control Group

  Eligibility

Ages Eligible for Study:   40 Years to 70 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population

Community Movement Disorder Clinic at Washington University St. Louis

Criteria

Inclusion Criteria:

  • PD Group:

    • Clinically definite PD
    • 40-70 years old
    • Hoehn and Yahr stage I,II,III
    • Currently treated with Levodopa/carbidopa

  • Control Group:

    • 40-70 years old
    • Spouses of PD Group preferred

Exclusion Criteria:

  • PD Group and Control Group:

    • Significant neurological problems
    • Significant current psychiatric diagnoses
    • Mini Mental Status Exam score < 24 (MMSE)
    • Any significant abnormality on brain imaging
    • MPTP exposure
    • Control Participants met the same exclusion criteria described above as well as a biological family history of PD
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00913640

Locations
United States, Missouri
Washington University School of Medicine
St. Louis, Missouri, United States, 63110
Sponsors and Collaborators
Washington University School of Medicine
National Institutes of Health (NIH)
Investigators
Principal Investigator: Tamara G Hershey, Ph.D. Washington University School of Medicine
  More Information

Additional Information:
Link to Dr. Hershey's Web Site  This link exits the ClinicalTrials.gov site

No publications provided

Responsible Party: Tamara G Hershey PhD.,, Washington University
ClinicalTrials.gov Identifier: NCT00913640     History of Changes
Other Study ID Numbers: 05-0203
Study First Received: June 1, 2009
Last Updated: July 14, 2009
Health Authority: United States: Institutional Review Board

Keywords provided by Washington University School of Medicine:
Prospective Memory Performance
Prospective Memory Outcome
Parkinson's Disease

Additional relevant MeSH terms:
Parkinson Disease
Parkinsonian Disorders
Basal Ganglia Diseases
Brain Diseases
 Central Nervous System Diseases
Nervous System Diseases
Movement Disorders
Neurodegenerative Diseases

ClinicalTrials.gov processed this record on May 23, 2013